Materials • NYSE
According to Zyberno, Constellium SE (CSTM) is not a buy — AVERAGE BUSINESS (55/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -4.9% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, Constellium SE (CSTM) trades at $26.98 against an estimated intrinsic value per share of $8.00 — a -100.0% Margin of Safety based on Owner Earnings of $243.00M TTM, projected at -50.0% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -4.9% weakens the case: based on the company's ROIC (9.0%) and reinvestment rate (0.2%), the business can fundamentally grow at 0.0% — but the current enterprise value implies the market expects 5.0%. This places CSTM in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -37.3% annually.
Over the trailing twelve months, CSTM generated $243.00M in Owner Earnings. Capital was deployed as follows: $28.00M returned via share buybacks, $402.00M invested in capital expenditures. Reinvestment rate: 0.2%. Owner Earnings have declined at 50.0% annually over the trailing five years using log-linear regression.